Jiangxi Yeli Medical Devices Co., Ltd.

Jiangxi Yeli Technology Group is a comprehensive group company integrating research and development, production, and sales of diagnostic reagents, diagnostic equipment, and medical consumables. The company headquarters is located in the Jiahai Industrial Park, Tianxiang Avenue, Nanchang City, Jiangxi Province. Under Yeli Group there are several subsidiaries including: Jiangxi Dongsen Technology Development Co., Ltd., Jiangxi Yeli Medical Devices Co., Ltd., Nanchang Yeli Biotechnology Co., Ltd., Nanchang Zhongshen Medical Devices Co., Ltd., and Nanchang Laokang Technology Co., Ltd.
The group's business covers five major fields: blood cell typing, chemiluminescence, flow cytometry, microbiology, and molecular diagnostics. It has established a research and development and production platform for molecular diagnostic equipment and reagents based on precision medicine. The company is equipped with a professional technical team in biomedical engineering, electronic information technology, mechanical and automation, and software technology. The expertise covers monoclonal antibodies, genetic diagnostics, immunodiagnostics, liquid phase chips, molecular biology, mechanical and automation, software engineering, and other fields, forming a multidisciplinary, knowledge-intensive, and capital-intensive high-tech research and development team. The company's research and development projects involve nearly 30 Class I, Class II, and Class III medical device projects. It has applied for 17 patents and 1 software copyright, and has established a comprehensive independent intellectual property system.
As of the end of 2019, the group company had nearly 200 employees, with approximately 65% holding a bachelor's degree or above. The sales team has nearly 100 people, with over 400 directly-operated outlets. In 2016, it acquired Nanchang Zhongshen Medical Devices Co., Ltd., embarking on a new journey of nationwide recruitment for disposable oxygen inhalation tube humidification bottles. In 2017, it secured the national lifetime agency for the molecular diagnostic product HLA-B27, using this as an opportunity to enter the national market. It has successively established liaison offices in Beijing, Henan, Hebei, Guangdong, Guangxi, Zhejiang, Fujian, Anhui, Hunan, Hubei, and other places. The development of markets outside the province has enabled Yeli Group to move toward the next stage with a more steady and confident pace.
The development history of Yeli Group is a history of arduous entrepreneurship, a history of unremitting self-improvement, and a history of forging ahead. Yeli people, adhering to the corporate philosophy of creating customer value and making every life ultimately brilliant, are steadily advancing toward the corporate goal of "becoming the Huawei of the medical industry." Jiangxi Yeli Technology Group will focus on the medical and health field for the long term, continuously create customer value, and rely on persistent and arduous pursuit to become the backbone of the national medical industry.